Press release
Palatin Technologies' UC Treatment Shows Remarkable 78% Clinical Response Rate in Phase 2 Topline Data - Potential Game-Changer for Millions Suffering from Ulcerative Colitis (NYSE: PTN)
Palatin Technologies (NYSE American: PTN)* just unveiled remarkable topline results from its Phase 2 study of PL8177 for ulcerative colitis (UC), demonstrating what could be a disruptive new treatment approach for this debilitating inflammatory bowel condition.
The data seems impressive - an extraordinary 78% of patients treated with PL8177 achieved clinical response compared to just 33% for placebo, with statistical significance (p
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Palatin Technologies' UC Treatment Shows Remarkable 78% Clinical Response Rate in Phase 2 Topline Data - Potential Game-Changer for Millions Suffering from Ulcerative Colitis (NYSE: PTN) here
News-ID: 3947959 • Views: …
More Releases from ABNewswire
FITABLE Launches StepMate: "10 Minutes a Day" Home Cardio Device Now Seeking U.S …
StepMate by FITABLE delivers powerful, 10-minute home cardio in a compact device-now on Kickstarter for U.S. backers.
FITABLE, a forward-thinking home fitness brand, today announces the launch of its Kickstarter campaign for StepMate: 10 Minutes a Day for Powerful Home Cardio. Designed from the ground up to bring effective, low-impact cardio into the home without bulky equipment, StepMate is now accepting U.S. pledges, with shipping exclusively to U.S. backers.
Image: https://www.abnewswire.com/upload/2025/10/72287d8af3268c804e69df67efc70a3e.jpg
The campaign…
Top Real Estate Agent in Napa, CA Launches SOVARA Real Estate, Bringing Lifestyl …
Napa, CA - October 10, 2025 - A new era of real estate arrives in Wine Country as SOVARA Real Estate officially launches under the leadership of award-winning Napa Valley professional Sierra Pujals. The boutique brokerage redefines the traditional model by blending editorial-style branding, curated marketing, and a client-first philosophy designed to reflect the way people truly live.
Napa Valley's real estate market has continued to evolve as buyers look beyond…
Total Remodeling and Repair Brings Expert Bathtub Remodeling to Local Homes with …
Total Remodeling and Repair specializes in bathtub remodeling with an emphasis on precision, reliability, and personalized service. As a top choice for those searching for bathtub remodeling near me, they are trusted for high-quality bathtub remodeling services and local bathtub remodeling projects that enhance comfort, style, and home value.
Homeowners today are looking for more than just surface-level upgrades - they want spaces that reflect quality, functionality, and personal comfort. At…
Salsa Vida Announces 3,000+ Verified Salsa Events, Multi-Language Expansion (EN/ …
Salsa Vida unveiled major milestones across its global salsa platform, including 3,000+ actively verified events in all 50 U.S. states and 55+ countries, full localization in English, Spanish, Japanese, and newly added German, and an accuracy-first QA system that pairs AI "deep research" with daily human review. A mobile-ready map view is slated for release, complementing comprehensive city/country guides, the web's largest Latin dance festival listings, and free dancer tools.
SAN…
More Releases for Palatin
Moderate Dry Eye Market Growth to Accelerate in Forecast Period (2023-2032), Del …
The Key Moderate Dry Eye Companies in the market include - Palatin Technologies, Novaliq, mc2 therapeutics, and others.
The Moderate Dry Eye market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Moderate Dry Eye pipeline products will significantly revolutionize the Moderate Dry Eye market dynamics.
DelveInsight's "Moderate Dry Eye Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding…
Mild Dry Eye Market Growth Projections 2023-2032: DelveInsight Analysis | Palati …
The Key Mild Dry Eye Companies in the market include - Palatin Technologies, Novaliq, mc2 therapeutics, and others.
The Mild Dry Eye market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Mild Dry Eye pipeline products will significantly revolutionize the Mild Dry Eye market dynamics.
DelveInsight's "Mild Dry Eye Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding…
Dry Eye Disease Market Growth Projections 2024-2034: DelveInsight Analysis | Pal …
The Key Dry Eye Disease Companies in the market include - Palatin Technologies, Novaliq, mc2 therapeutics, and others.
The Dry Eye Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Dry Eye Disease pipeline products will significantly revolutionize the Dry Eye Disease market dynamics.
DelveInsight's "Dry Eye Disease Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding…
Dry Eye Disease Market to Expand Significantly by 2034, States DelveInsight Repo …
The Dry Eye Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Dry Eye Disease pipeline products will significantly revolutionize the Dry Eye Disease market dynamics.
DelveInsight's "Dry Eye Disease Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Dry Eye Disease, historical and forecasted epidemiology as well as the Dry Eye…
Palatin Technologies' Obesity Drug Receives FDA Orphan Designation; Phase 2 Resu …
Palatin Technologies (NYSE: PTN)* and their latest developments: Palatin's Oral MC4R Agonist Gets FDA Orphan Drug Status; Phase 2 Results in Drug Targeting $44 Billion Obesity Market Expected Any Day According to the Company, alongside results from ulcerative colitis trial; Only Oral Option in Market Currently Dominated by Injections Uniquely Positioning Palatin
In an exciting development for the biopharma market, Palatin Technologies (NYSE: PTN)* announced that it has secured FDA orphan…
Dry Eye Disease Market to Show Incremental Growth, asserts DelveInsight | Promin …
DelveInsight's "Dry Eye Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Dry Eye Disease, historical and forecasted epidemiology as well as the Dry Eye Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Dry Eye Disease market report provides current treatment practices, emerging drugs, Dry Eye Disease market share of the individual therapies, current and forecasted…
